Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma

NCT05846724 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The lack of adequate funding has made it impossible to continue with the clinical study As this study was not initiated, no subject was included and no data was collected,thus no result can be obtained SPONSOR\_DECISION End of trial date:15 Oct 2025

Conditions

Interventions

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico